#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital hypotransferrinaemia Thrombocytopenia Cholangitis sclerosing Infertility male Craniocerebral injury Gastrointestinal stromal tumour Squamous cell carcinoma of the hypopharynx Nephroblastoma Bronchiolitis Blood iron increased Human papilloma virus immunisation Idiopathic inflammatory myopathy Philadelphia positive chronic myeloid leukaemia Growth hormone deficiency Heavy menstrual bleeding More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Basic Information Choroid melanoma – Basic Information Factor IX deficiency – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Haemophagocytic lymphohistiocytosis – Diagnostics Cystic fibrosis Choroid melanoma – Trials in Disease Skin angiosarcoma – Trials in Disease Pelizaeus-Merzbacher disease – Diagnostics Progressive supranuclear palsy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Opium, Standardized Powdered Alglucosidase Alfa ABY-271 SOVATELTIDE Hct116-B A52 Idelalisib Povorcitinib ELTANEXOR Lna043 Clopidogrel Hydrogen Sulfate Ht-29-A Vericiguat Bi-1910 Amitriptyline LUNRESERTIB Namilumab Ly3541860 Gskvx000000014593 Evencaleucel More therapies…

    Learn about Your Condition

    Autoimmune uveitis Osteopenia Dyslipidaemia Staphylococcal infection Bone metabolism disorder Albuminuria Mitochondrial DNA depletion Rosai-Dorfman syndrome EGFR gene mutation B-cell type acute leukaemia Hyperkalaemia Macular degeneration Thrombosis prophylaxis Somatic symptom disorder Laparotomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Pain Relief Using Levobupivacaine Hydrochloride for Patients Undergoing Laparoscopic Colorectal Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Levobupivacaine Hydrochloride
    Spain

  • Study on Edoxaban and Drug Combination for Patients with Atrial Fibrillation Needing Anticoagulation After Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Apixaban
    • Dabigatran
    • Edoxaban
    Germany

  • Study on Phenoxymethylpenicillin for Patients with Severe Streptococcus Group A-Negative Acute Tonsillitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tonsillitis
    Investigated Drugs:
    • Benzathine Benzylpenicillin
    Sweden

  • Study of Mirikizumab for Children and Teens with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium France Germany Italy The Netherlands +4

  • Study on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cytisine
    Poland

  • Long-Term Safety Study of NTLA-2002 for Patients with Hereditary Angioedema, Using Messenger RNA Encoding Cas9 and HU-G012267

    Recruiting

    1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Lonvoguran
    • Ziclumeran
    France Germany The Netherlands
Previous Page
1 … 544 545 546 547 548 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!